•  
  •  
  •  
  •  

2025-12-05 23:44:49

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Pritish Nandy Communications announces Four More Shots Please! Final Season to Premiere on Prime Video December 19
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Fineotex Chemical Ltd announces Strategic Acquisition of a Leading U.S. Specialty Oilfield Chemicals Group
  • The University of Western Australia and HCLTech launch globally accessible micro-credential programs in AI and cybersecurity
  • ACS Technologies Ltd receives order worth Rs. 64.98 lakhs

Keywords Selected:  Relonchem

Stock Report

  • Relonchem Limited receives Marketing Authorization for its two products
  • Relonchem Limited receives Marketing Authorization for two of its products
  • Relonchem Limited receives Marketing Authorization for its products
  • Relonchem Limited receives Marketing Authorization for its products
  • Relonchem Limited receives Marketing Authorization for the product Oxybutynin hydrochloride 2.5mg/5ml Oral Solution
  • Relonchem Ltd receives Marketing Authorization for the product Gabapentin 50 mg/ml oral solution
  • Relonchem Limited receives Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA
  • Relonchem Ltd receives Marketing Authorization for Ibuprofen and Paracetamol tablets
  • Relonchem Limited receives Marketing Authorization from UKMHRA for its products
  • UK Relonchem Ltd, receives Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets
  • Relonchem Limited receives UKMHRA Marketing Authorization for its products
  • Relonchem Ltd receives Marketing Authorisation for the product Levetiracetam Relonchem 100 mg/mL Oral Solution
  • Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
  • Marksans Pharma Limited announces UK MHRA approval for Loperamide 2mg Hard Capsules

Latest Post

  • Pritish Nandy Communications announces Four More Shots Please! Final Season to Premiere on Prime Video December 19
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Fineotex Chemical Ltd announces Strategic Acquisition of a Leading U.S. Specialty Oilfield Chemicals Group
  • The University of Western Australia and HCLTech launch globally accessible micro-credential programs in AI and cybersecurity
  • ACS Technologies Ltd receives order worth Rs. 64.98 lakhs


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024